NPS Pharma Says sNDA Submitted for Gattex STEPS 2 Data, Shows Sustained Effects
October 02, 2013 at 08:13 AM EDT
NPS Pharmaceuticals, Inc. (NASDAQ: NPSP ), a biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, today reported that results from the
